Low-Barrier Hydrogen Bond Determines Target-Binding Affinity and Specificity of the Antitubercular Drug Bedaquiline - Publication - Bridge of Knowledge

Search

Low-Barrier Hydrogen Bond Determines Target-Binding Affinity and Specificity of the Antitubercular Drug Bedaquiline

Abstract

The role of short strong hydrogen bonds (SSHB) in ligand-target binding remains largely unexplored, thereby hin- dering a potentially important avenue in the rational drug de- sign. Here, we investigate the interaction between bedaquiline (Bq), a potent anti-tuberculosis drug, and the mycobacterial ATP synthase, to unravel the role of a specific hydrogen bond to a conserved acidic residue in the target affinity and specificity. Our ab initio molecular dynamics simulations reveal that this bond belongs to the SSHB category and accounts for a substan- tial fraction of the target binding energy. We also demonstrate that the presence of an extra acidic residue (D32), found exclu- sively in mycobacteria, cooperatively enhances the HB strength ensuring the specificity for the mycobacterial target. Consis- tently, we show that the removal of D32 markedly weakens the affinity, leading to Bq resistance associated with mutations of D32 to non-acidic residues. By designing simple Bq analogs, we then explore the possibility to overcome the resistance and po- tentially broaden the Bq antimicrobial spectrum by making the SSHB independent on the presence of the extra acidic residue.

Citations

  • 0

    CrossRef

  • 0

    Web of Science

  • 0

    Scopus

Cite as

Full text

full text is not available in portal

Keywords

Details

Category:
Articles
Type:
artykuły w czasopismach
Published in:
ACS Medicinal Chemistry Letters no. 15, pages 265 - 269,
ISSN: 1948-5875
Language:
English
Publication year:
2024
Bibliographic description:
Słabońska J., Sappati S., Marciniak A., Czub J.: Low-Barrier Hydrogen Bond Determines Target-Binding Affinity and Specificity of the Antitubercular Drug Bedaquiline// ACS Medicinal Chemistry Letters -, (2024), s.265-269
DOI:
Digital Object Identifier (open in new tab) 10.1021/acsmedchemlett.3c00509
Sources of funding:
  • COST_FREE
Verified by:
Gdańsk University of Technology

seen 24 times

Recommended for you

Meta Tags